The transition from mild to moderate-to-severe chronic plaque psoriasis

被引：0
|
作者：
Bellinato, Francesco [1 ,3 ]
Gisondi, Paolo [1 ]
Mioso, Guido [2 ]
Mason, Elena [1 ]
Straiotto, Danny [2 ]
Piaserico, Stefano [2 ]
Girolomoni, Giampiero [1 ]
机构：
[1] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy
[2] Univ Padua, Dept Med, Sect Dermatol, Padua, Italy
[3] Univ Verona, Dept Med, Sect Dermatol & Venereol, Piazzale A Stefani 1, I-37126 Verona, Italy
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 37卷 / 10期
关键词：
LATE-ONSET;
D O I：
10.1111/jdv.19208
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E1215 / E1217
页数：3
相关论文
共 50 条
  • [21] Incidence of infections in clinical trials of tildrakizumab for moderate-to-severe chronic plaque psoriasis
    Crowley, Jeffrey
    Leonardi, Craig
    Sturgill-Koszycki, Sheila
    Menter, Alan
    Mendelsohn, Alan M.
    Li, Qing
    Cichanowitz, Nicole
    Gree, Stuart
    la Rosa, Carmen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB166 - AB166
  • [22] Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics
    Sator, P.
    Richter, L.
    Saxinger, W.
    Vasiljevic, M.
    Stingl, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (09) : 1742 - 1749
  • [23] Efalizumab A Review of its Use in the Management of Chronic Moderate-to-Severe Plaque Psoriasis
    Frampton, James E.
    Plosker, Greg L.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2009, 10 (01) : 51 - 72
  • [24] Oral dimethyl fumarate available for adults with moderate-to-severe chronic plaque psoriasis
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2017, 78 (10) : 549 - 549
  • [25] Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
    Papp, Kim A.
    Blauvelt, Andrew
    Bukhalo, Michael
    Gooderham, Melinda
    Krueger, James
    Lacour, Jean-Philippe
    Menter, Alan
    Philipp, Sandra
    Sofen, Howard
    Tyring, Stephen
    Berner, Beate R.
    Visvanathan, Sudha
    Pamulapati, Chandrasena
    Bennett, Nathan
    Flack, Mary
    Scholl, Paul
    Padula, Steven J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (16): : 1551 - 1560
  • [26] Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis
    Fioranelli, Massimo
    Roccia, Maria Grazia
    Lotti, Torello
    DERMATOLOGIC THERAPY, 2017, 30 (05)
  • [27] The role of biologics in the treatment of moderate-to-severe plaque psoriasis
    Puig, Lluis
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (01): : 28 - 35
  • [28] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Prieto-Perez, Rocio
    Llamas-Velasco, Mar
    Cabaleiro, Teresa
    Solano-Lopez, Guillermo
    Marquez, Beatriz
    Roman, Manuel
    Ochoa, Dolores
    Talegon, Maria
    Dauden, Esteban
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2017, 18 (02) : 157 - 164
  • [29] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Dauden, E.
    Prieto-Perez, R.
    Llamas-Velasco, M.
    Cabaleiro, T.
    Abad-Santos, F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S188 - S188
  • [30] Therapeutic inertia in the management of moderate-to-severe plaque psoriasis
    Halioua, B.
    Corgibet, F.
    Maghia, R.
    Hello, S.
    Caillet, G.
    Nicolas, C.
    Riboulet, J. -L.
    Mahe, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (01) : E30 - E32
12345